Abstract
Microorganisms prefer to live in three-dimensional self-organized communities (biofilms), and this behavior provides microbial pathogens inhabiting various sites in the human body or on medical devices with survival advantages. In fact, pathogens in the biofilm stage exhibit up to a thousandfold more tolerance to conventional antimicrobial agents, and thus, they are difficult to eradicate and biofilms generated during acute infections become persistent, chronic, and recurrent. Consequently, novel strategies are being sought to control biofilm associated infections. The developmental strategies used include improved drug delivery and the penetration of biofilm matrices, and in particular, natural products that interfere with virulence and cross talk between microbial cells are being investigated as potential anti-biofilm agents. This article provides an overview of existing and promising biofilm control strategies based on plant and microbial products. Control strategies like quorum sensing inhibition, microbial antibiosis, and the uses of phages and probiotics are reviewed along with current developments in high throughput screening and in our understanding of structure activity relationships related to the regulation of biofilms by small molecules.
Keywords: Biofilms, natural products, pathogenicity, phage therapy, quorum sensing, small molecules.
Current Pharmaceutical Biotechnology
Title:Novel Strategies for Combating Pathogenic Biofilms Using Plant Products and Microbial Antibiosis
Volume: 17 Issue: 2
Author(s): Mohd S.A. Khan and Jintae Lee
Affiliation:
Keywords: Biofilms, natural products, pathogenicity, phage therapy, quorum sensing, small molecules.
Abstract: Microorganisms prefer to live in three-dimensional self-organized communities (biofilms), and this behavior provides microbial pathogens inhabiting various sites in the human body or on medical devices with survival advantages. In fact, pathogens in the biofilm stage exhibit up to a thousandfold more tolerance to conventional antimicrobial agents, and thus, they are difficult to eradicate and biofilms generated during acute infections become persistent, chronic, and recurrent. Consequently, novel strategies are being sought to control biofilm associated infections. The developmental strategies used include improved drug delivery and the penetration of biofilm matrices, and in particular, natural products that interfere with virulence and cross talk between microbial cells are being investigated as potential anti-biofilm agents. This article provides an overview of existing and promising biofilm control strategies based on plant and microbial products. Control strategies like quorum sensing inhibition, microbial antibiosis, and the uses of phages and probiotics are reviewed along with current developments in high throughput screening and in our understanding of structure activity relationships related to the regulation of biofilms by small molecules.
Export Options
About this article
Cite this article as:
Khan S.A. Mohd and Lee Jintae, Novel Strategies for Combating Pathogenic Biofilms Using Plant Products and Microbial Antibiosis, Current Pharmaceutical Biotechnology 2016; 17 (2) . https://dx.doi.org/10.2174/1389201016666150907113228
DOI https://dx.doi.org/10.2174/1389201016666150907113228 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Call for Papers in Thematic Issues
Artificial Intelligence in Bioinformatics
Bioinformatics is an interdisciplinary field that analyzes and explores biological data. This field combines biology and information system. Artificial Intelligence (AI) has attracted great attention as it tries to replicate human intelligence. It has become common technology for analyzing and solving complex data and problems and encompasses sub-fields of machine ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Invasive Aspergillosis in Children and Adolescents
Current Pharmaceutical Design Optimal antibiotic dosage for chronic kidney disease patient: a pharmacological manual for oral clinicians
Recent Patents on Anti-Infective Drug Discovery Acute Tonsillitis
Infectious Disorders - Drug Targets Potential Therapeutic Application of Chondroitin Sulfate/Dermatan Sulfate
Current Drug Discovery Technologies Use of Diffusion- and Perfusion-Weighted Magnetic Resonance Imaging in Drug Development for Ischemic Stroke
Current Drug Targets - CNS & Neurological Disorders Antibiotic Susceptibility and Treatment of Brucellosis
Recent Patents on Anti-Infective Drug Discovery High-Level Aminoglycoside Resistance in Enterococcus Faecalis and Enterococcus Faecium; as a Serious Threat in Hospitals
Infectious Disorders - Drug Targets Odontogenic Infections in the Etiology of Infective Endocarditis
Cardiovascular & Hematological Disorders-Drug Targets Antimicrobial Strategies Effective Against Infectious Bacterial Biofilms
Current Medicinal Chemistry Ophthalmological and Otological Manifestations in the Antiphospholipid Syndrome
Current Rheumatology Reviews Contraception in Women with Medical Conditions
Current Women`s Health Reviews The Role of Hypoxia and Platelets in Air Travel-Related Venous Thromboembolism
Current Pharmaceutical Design Ethnic and Geographical Differences in Ischaemic Stroke Among Young Adults
Current Vascular Pharmacology Antibiotic Prophylaxis in Urologic Prosthetic Surgery
Current Pharmaceutical Design Cardiovascular Diseases in Pregnancy - A Brief Overview
Current Cardiology Reviews Pharmacological Treatments for Obesity
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) The Guanylyl Cyclase Inhibition by MB as Vasoplegic Circulatory Shock Therapeutical Target
Current Drug Targets Probiotics in Intestinal and Non-Intestinal Infectious Diseases – Clinical Evidence
Current Pharmaceutical Design From Vancomycin to Oritavancin: The Discovery and Development of a Novel Lipoglycopeptide Antibiotic
Anti-Infective Agents in Medicinal Chemistry Natural Products Towards the Discovery of Potential Future Antithrombotic Drugs
Current Pharmaceutical Design